Trademark Overview
On Tuesday, October 4, 2022, a trademark application was filed for FORTITUDE with the United States Patent and Trademark Office. The USPTO has given the FORTITUDE trademark a serial number of 97618584. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Thursday, February 1, 2024. This trademark is owned by Avidity Biosciences, Inc.. The FORTITUDE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; all of the foregoing excluding diagnostic preparations, reagents, and products
Scientific research in the nature of conducting clinical trials for others in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; medical and scientific research, namely, conducting clinical trials for others for oligonucleotide-based therapeutics; all of the foregoing excluding medical and scientific research related to diagnostic preparations, reagents, and products
